Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Unexplained Symptoms and Hidden Inflammation in Patients With Crohn's Disease.

Sorrentino D, Nguyen VQ.

Clin Gastroenterol Hepatol. 2019 Mar 7. pii: S1542-3565(19)30252-6. doi: 10.1016/j.cgh.2019.03.004. [Epub ahead of print] No abstract available.

PMID:
30853614
2.

Blood-derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation.

Somineni HK, Venkateswaran S, Kilaru V, Marigorta UM, Mo A, Okou DT, Kellermayer R, Mondal K, Cobb D, Walters TD, Griffiths A, Noe JD, Crandall WV, Rosh JR, Mack DR, Heyman MB, Baker SS, Stephens MC, Baldassano RN, Markowitz JF, Dubinsky MC, Cho J, Hyams JS, Denson LA, Gibson G, Cutler DJ, Conneely KN, Smith AK, Kugathasan S.

Gastroenterology. 2019 Feb 16. pii: S0016-5085(19)30397-X. doi: 10.1053/j.gastro.2019.01.270. [Epub ahead of print]

PMID:
30779925
3.

Crohn's disease is frequently complicated by giardiasis.

Scheurlen C, Kruis W, Spengler U, Weinzierl M, Paumgartner G, Lamina J.

Scand J Gastroenterol. 1988 Sep;23(7):833-9.

PMID:
3227299
4.

Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis.

Boirivant M, Marini M, Di Felice G, Pronio AM, Montesani C, Tersigni R, Strober W.

Gastroenterology. 1999 Mar;116(3):557-65.

PMID:
10029614
5.

Serial intralesional injections of infliximab in small bowel Crohn's strictures are feasible and might lower inflammation.

Hendel J, Karstensen JG, Vilmann P.

United European Gastroenterol J. 2014 Oct;2(5):406-12. doi: 10.1177/2050640614547805.

6.

Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.

Johnson FR, Hauber B, Özdemir S, Siegel CA, Hass S, Sands BE.

J Manag Care Pharm. 2010 Oct;16(8):616-28.

7.

Why does Crohn's disease usually occur in terminal ileum?

Caprilli R.

J Crohns Colitis. 2008 Dec;2(4):352-6. doi: 10.1016/j.crohns.2008.06.001. Epub 2008 Aug 8.

PMID:
21172238
8.

The role of topical therapy for perianal fistulizing Crohn's disease: are we forgetting something?

Ribaldone DG, Resegotti A, Pellicano R, Astegiano M, Saracco GM, Morino M.

Minerva Gastroenterol Dietol. 2019 Feb 12. doi: 10.23736/S1121-421X.19.02565-0. [Epub ahead of print]

PMID:
30759975
9.
10.

The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease.

Cucino C, Sonnenberg A.

Am J Gastroenterol. 2001 Jul;96(7):2107-12.

PMID:
11467640
11.

Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn's disease.

Muñoz-Juárez M, Yamamoto T, Wolff BG, Keighley MR.

Dis Colon Rectum. 2001 Jan;44(1):20-5; discussion 25-6.

PMID:
11805559
12.

Frequency of continuing mucosal inflammation in clinically inactive Crohn's disease.

Arnott ID, Drummond HE, Ghosh S.

Scott Med J. 2001 Oct;46(5):136-9.

PMID:
11771492
13.

The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome.

Lahiff C, Safaie P, Awais A, Akbari M, Gashin L, Sheth S, Lembo A, Leffler D, Moss AC, Cheifetz AS.

Aliment Pharmacol Ther. 2013 Apr;37(8):786-94. doi: 10.1111/apt.12262. Epub 2013 Feb 21.

14.

Angiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn's Disease.

Knod JL, Crawford K, Dusing M, Collins MH, Chernoguz A, Frischer JS.

J Gastrointest Surg. 2016 Mar;20(3):624-30. doi: 10.1007/s11605-015-3002-1. Epub 2015 Nov 3.

PMID:
26530519
15.

Bile acid metabolism and plasma protein turnover in Crohn's disease.

Lenz K, Jensen KB, Jarnum S.

Scand J Gastroenterol. 1976;11(7):721-7.

PMID:
996438
16.

Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease.

Visekruna A, Slavova N, Dullat S, Gröne J, Kroesen AJ, Ritz JP, Buhr HJ, Steinhoff U.

Int J Colorectal Dis. 2009 Oct;24(10):1133-9. doi: 10.1007/s00384-009-0679-1. Epub 2009 Mar 10.

17.

MRI features of perianal fistulas: is there a difference between Crohn's and non-Crohn's patients?

Oliveira IS, Kilcoyne A, Price MC, Harisinghani M.

Abdom Radiol (NY). 2017 Apr;42(4):1162-1168. doi: 10.1007/s00261-016-0989-z.

PMID:
27885389
18.

Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.

Watanabe Y, Miyoshi N, Fujino S, Takahashi H, Haraguchi N, Hata T, Matsuda C, Yamamoto H, Doki Y, Mori M, Mizushima T.

Dig Dis Sci. 2019 Feb 26. doi: 10.1007/s10620-019-05553-2. [Epub ahead of print]

PMID:
30806860
19.

Profoundly Expanded T-cell Clones in the Inflamed and Uninflamed Intestine of Patients With Crohn's Disease.

Doorenspleet ME, Westera L, Peters CP, Hakvoort TBM, Esveldt RE, Vogels E, van Kampen AHC, Baas F, Buskens C, Bemelman WA, D'Haens G, Ponsioen CY, Te Velde AA, de Vries N, van den Brink GR.

J Crohns Colitis. 2017 Jul 1;11(7):831-839. doi: 10.1093/ecco-jcc/jjx012.

PMID:
28158397
20.

A simple method for assessing intestinal inflammation in Crohn's disease.

Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I.

Gut. 2000 Oct;47(4):506-13.

Supplemental Content

Support Center